226 related articles for article (PubMed ID: 24166587)
1. Successful treatment of POEMS syndrome with bortezomib and dexamethasone, combined with radiotherapy, and followed by autologous stem cell transplantation.
Ishii Y; Yamazaki E; Ishiyama Y; Yamamoto E; Hattori Y; Hagihara M; Tomita N; Ishigatsubo Y
Int J Hematol; 2013 Dec; 98(6):723-8. PubMed ID: 24166587
[TBL] [Abstract][Full Text] [Related]
2. [POEMS syndrome. An interdisciplinary clinical challenge].
Braun SA; Albrecht P; Methner A; Hanneken S
Hautarzt; 2011 Oct; 62(10):722-5. PubMed ID: 21915731
[TBL] [Abstract][Full Text] [Related]
3. Effective induction therapy with subcutaneous administration of bortezomib for newly diagnosed POEMS syndrome: a case report and a review of the literature.
Zeng K; Yang JR; Li J; Wei Q; Yang YM; Liu T; Niu T
Acta Haematol; 2013; 129(2):101-5. PubMed ID: 23171959
[TBL] [Abstract][Full Text] [Related]
4. [Rapid improvement of fluid retention with lenalidomide plus low-dose dexamethasone for POEMS syndrome relapsed after autologous peripheral blood stem cell transplantation].
Ohashi K; Yokoyama A; Kagoo T; Hosoda T; Yamamoto R; Yoneda M; Kudo M; Boku S; Ueno H; Yano T
Rinsho Ketsueki; 2013 Jul; 54(7):670-4. PubMed ID: 23912352
[TBL] [Abstract][Full Text] [Related]
5. POEMS Syndrome: Therapeutic Options.
Jaccard A
Hematol Oncol Clin North Am; 2018 Feb; 32(1):141-151. PubMed ID: 29157615
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib and dexamethasone as first-line therapy for a patient with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes syndrome complicated by renal failure.
Li J; Zhang W; Kang WY; Cao XX; Duan MH; Zhou DB
Leuk Lymphoma; 2012 Dec; 53(12):2527-9. PubMed ID: 22553961
[No Abstract] [Full Text] [Related]
7. Sequential treatment with bortezomib plus dexamethasone followed by autologous hematopoietic stem cell transplantation in patients with multiple myeloma.
Zheng D; Li J; Huang BH; Liu JR; Zou WY; Su C
Chin Med J (Engl); 2012 Dec; 125(24):4454-9. PubMed ID: 23253719
[TBL] [Abstract][Full Text] [Related]
8. [Autologous hematopoietic stem cell transplantation following bortezomib-based chemotherapy for one case with POEMS syndrome].
Li LH; Zhang R; Tang XW
Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):733. PubMed ID: 22339906
[No Abstract] [Full Text] [Related]
9. New advances in the diagnosis and treatment of POEMS syndrome.
Li J; Zhou DB
Br J Haematol; 2013 May; 161(3):303-15. PubMed ID: 23398538
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report.
Taenaka R; Shimokawa S; Katayama A; Nagao T; Obara T; Nishimura N; Tsujimoto A; Kohno K; Aoki K; Ogawa R
J Med Case Rep; 2022 Aug; 16(1):311. PubMed ID: 35978379
[TBL] [Abstract][Full Text] [Related]
11. Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial.
Kim HJ; Yoon SS; Lee DS; Sohn SK; Eom HS; Lee JL; Chung JS; Kim K; Suh C; Won JH; Kim JS; Park JS; Kang HJ; Seong CM; Kim CS; Lee SJ; Lee JH
Ann Hematol; 2012 Feb; 91(2):249-56. PubMed ID: 21789621
[TBL] [Abstract][Full Text] [Related]
12. Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion.
Oyama T; Taoka K; Chiba A; Masamoto Y; Ikemura M; Honda A; Maki H; Kurokawa M
Int J Hematol; 2023 Mar; 117(3):463-467. PubMed ID: 36202948
[TBL] [Abstract][Full Text] [Related]
13. POEMS Syndrome: Indian Experience From a Tertiary-Care Institute.
Pramanik R; Sharma A; Sharma A; Gogia A; Sahoo RK; Malik PS; Padma MV; Cyriac SL; Kumar L
Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):e536-e544. PubMed ID: 31262669
[TBL] [Abstract][Full Text] [Related]
14. POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) treated with autologous hematopoietic stem cell transplantation: a case report and literature review.
Arana C; Pérez de León JA; Gómez-Moreno G; Pérez-Cano R; Martín Hernández T
Am J Case Rep; 2015 Mar; 16():124-9. PubMed ID: 25726020
[TBL] [Abstract][Full Text] [Related]
15. [Bortezomib-based induction therapy followed by autologous hematopoietic stem cell transplantation in multiple myeloma].
Huang B; Li J; Liu J; Gu J; Zheng D; Xu D; Zou W; Wang H
Zhonghua Nei Ke Za Zhi; 2014 Nov; 53(11):865-72. PubMed ID: 25586356
[TBL] [Abstract][Full Text] [Related]
16. [New treatment strategy for Crow-Fukase (POEMS) syndrome].
Kuwabara S
Rinsho Shinkeigaku; 2010 Nov; 50(11):794-6. PubMed ID: 21921444
[TBL] [Abstract][Full Text] [Related]
17. [Treatment for POEMS syndrome with subcutaneous administration of bortezomib followed by autologous peripheral blood stem cell transplantation: a case report and literatures review].
Zeng K; Liu ZG; Yang JR; Hou L; Yang YM; Liu T; Niu T
Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):550-2. PubMed ID: 23827121
[No Abstract] [Full Text] [Related]
18. Ixazomib Combined With Autologous Stem Cell Transplantation for POEMS Syndrome: A Case Report and Meta-Analysis.
Ma J; Wang X; Lu H; Liang Z; Wang L
Technol Cancer Res Treat; 2022; 21():15330338221123634. PubMed ID: 36579839
[No Abstract] [Full Text] [Related]
19. Bortezomib plus dexamethasone as first-line therapy for patients with POEMS syndrome.
Gao XM; Yu YY; Zhao H; Cai H; Zhang L; Cao XX; Zhou DB; Li J
Ann Hematol; 2021 Nov; 100(11):2755-2761. PubMed ID: 34331562
[TBL] [Abstract][Full Text] [Related]
20. [Bortezomib plus dexamethasone treatment followed by reduced-intensity allogeneic stem cell transplantation for multiple myeloma refractory to high-dose chemotherapy with autologous transplantation].
Hayashi T; Yasui H; Kawakami K; Ikeda H; Takahashi F; Kobayashi T; Nishimura S; Ishida T; Imai K; Shinomura Y
Rinsho Ketsueki; 2011 Mar; 52(3):136-41. PubMed ID: 21471701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
